Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccines Despite Similar Levels of Circulating Immunoglobulins

Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccines Despite Similar Levels of Circulating Immunoglobulins

The last seven years have seen the greatest surge of Ebola virus disease (EVD) cases in equatorial Africa, including the 2013–2016 epidemic in West Africa and the recent epidemics in the Democratic Republic of Congo (DRC). The vaccine clinical trials that took place in West Africa and the DRC, as we...

Full description

Bibliographic Details
Main Authors: Till Koch, Monika Rottstegge, Paula Ruibal, Sergio Gomez-Medina, Emily V. Nelson, Beatriz Escudero-Pérez, Matthias Pillny, My Linh Ly, Fara Raymond Koundouno, Joseph Akoi Bore, N’Faly Magassouba, Christine Dahlke, Stephan Günther, Miles W. Carroll, Marylyn M. Addo, César Muñoz-Fontela
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Viruses
Subjects:
Ebola virus
VSV
vaccine
antibodies
immune memory.
Online Access:https://www.mdpi.com/1999-4915/12/9/915

Internet

https://www.mdpi.com/1999-4915/12/9/915

Similar Items